Are we still missing the mark with randomised controlled trial abstracts?
Adherence to the Consolidated Standards of Reporting Trials for Abstracts continues to be inadequate, nearly 15 years after their release.
New CONSORT extension for trials using cohorts and routinely collected data: CONSORT-ROUTINE
Find out what’s in the new CONSORT-ROUTINE checklist for randomised controlled trials using cohorts and routinely collected data.
[VIDEO] Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
Meeting report: summary of day 1 of the 2019 ISMPP Annual Meeting
Missed the 15th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
Disparities claimed between stance and action on clinical trial outcome reporting by top medical journals
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
In memory of Professor Doug Altman
The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
No improvement in reporting of non-pharmacological interventions in 13 years
The CONSORT extension for reporting non-pharmacological interventions was introduced in 2008. A recent study looks at the impact of this guidance on reporting standards.
Adherence to CONSORT for Abstracts – still room for improvement
An analysis of journal article abstracts provides further insight into the role of reporting guidelines and medical writers in the transparent reporting of clinical trial data.